Search

Displaying results 21 - 28 of 28 in total
  1. Indication

    Locally advanced Urothelial Carcinoma

    go.drugbank.com/conditions/DBCOND0089492
    Drugs: Avelumab · Durvalumab · Nivolumab · Pembrolizumab
  2. Indication

    Muscle-invasive Bladder Cancer

    go.drugbank.com/conditions/DBCOND0042339
    Drugs: Atezolizumab · Durvalumab · Enfortumab vedotin · Pembrolizumab
  3. Drug

    Tiragolumab

    go.drugbank.com/drugs/DB16409
    Investigational

    Tiragolumab is under investigation in clinical trial NCT04513925 (A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-small

  4. Indication

    Resectable Non-small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0068626
    Drugs: Durvalumab · Hyaluronidase (human recombinant) · Nivolumab · Pembrolizumab
  5. Indication

    Extensive-stage Small Cell Lung Cancer (ES-SCLC)

    go.drugbank.com/conditions/DBCOND0168067
    Drugs: Atezolizumab · Durvalumab · Lurbinectedin · Serplulimab · Tarlatamab · Tislelizumab
  6. Indication

    Metastatic Urothelial Carcinoma (UC)

    go.drugbank.com/conditions/DBCOND0073677
    Drugs: Durvalumab · Hyaluronidase (human recombinant) · Nivolumab · Pembrolizumab · Pemetrexed
  7. Indication

    Unresectable Hepatocellular Carcinoma (HCC)

    go.drugbank.com/conditions/DBCOND0083730
    Drugs: Atezolizumab · Bevacizumab · Durvalumab · Ipilimumab · Lenvatinib · Nivolumab +2 more
  8. Indication

    Metastatic Non-Small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0043377
    Drugs: Adagrasib · Afatinib · Amivantamab · Atezolizumab · Binimetinib · Brigatinib +32 more